The global tissue expanders market size is predicted to increase from USD 747.47 million in 2024 to approximately USD 1,309.69 million by 2033, expanding at a CAGR of 6.43% from 2024 to 2033. The tissue expanders market has expanded due to improvements in breast reconstruction materials and surgical methods.
The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/4017
Tissue Expanders Market: An Overview and Industry Potential
Tissue expanders are widely used in plastic and reconstructive surgery. They use sophisticated technology to regenerate skin and create new tissue to repair and rebuild soft tissue defects throughout the body. One of the primary drivers of the tissue expanders market is the increasing number of breast cancer cases worldwide.
The market is seen to expand at a rapid pace as the innovation in cell and tissue preservation takes place across the globe. Breast reconstruction after mastectomy, using tissue expanders, is a vital aspect of post-cancer treatment, driving the demand for these devices. According to the World Health Organization (WHO), breast cancer remains the most common cancer among women globally, increasing the need for surgical procedures and post-operative care, including tissue expansion.
Major Trends in Tissue Expanders Market:
·
Growing Adoption of Breast Reconstruction
Post-Mastectomy: ·
Technological Advancements in Tissue Expander
Design: ·
Rise of Minimally Invasive Procedures: For questions or customization requests,
please reach out to us @ sales@precedenceresearch.com
| +1 804 441 9344 Tissue Expanders Market Report Coverage Report
Attribute Key
Statistics Market Size
in 2024 USD 747.47
Million Market Size
in 2025 USD 795.53
Million Market Size
by 2033 USD 1,309.69
Million Growth Rate
from 2024 to 2033 6.43% U.S. Market
Size in 2023 USD 221.23
Million U.S. Market
Size by 2033 USD 412.55
Million Base Year 2023 Forecast
Period 2024 to 2033 Leading
Region North America Fastest
Growing Region Asia-Pacific Segments
Covered By Shape, By
Application, and By End-use, and By Region Regions
Covered North
America, Europe, Asia-Pacific, Latin America, and Middle East & Africa Companies
Covered Mentor
Worldwide LLC, PMT Corporation, AbbVie Inc., Sientra, Inc., Sebbin, Guangzhou
Wanhe Plastic Material Co.,Ltd, KOKEN CO., LTD., GC Aesthetics, POLYTECH
Health & Aesthetics GmbH, and Others.
Explore Our Related Reports: ·
Tissue Engineering Market: The
global tissue engineering market size accounted for USD 11.7
billion in 2024 and is expected to reach around USD 36.34 billion by 2034,
expanding at a CAGR of 12% from 2024 to 2034. Increasing awareness is the
progress in the popularity of tissue regeneration technology due to
effective products and reduced residual costs. Tissue engineering has become
popular in many fields, including urological devices, orthopedics, burn
therapy, and wound and burn management. Tissue engineering is beneficial
in treating pediatric patients. ·
Soft Tissue Repair Market: The
global soft tissue repair market size was valued at USD 7.03
billion in 2023 and is anticipated to reach around USD 10.94 billion by 2033,
growing at a CAGR of 4.52% from 2024 to 2034. The occurrence of soft tissue
injuries may spur the growth of the tissue repair industry. The expanding
technological advancements in the market include the development of novel
biomaterials, safe surgical procedures, and improved healing techniques. Insights from Key Regions U.S. Tissue Expanders Market Size and
Growth 2024 to 2033 The U.S. tissue expanders market size is
calculated at USD 221.23 million in 2023 and is estimated to be worth around
USD 412.55 million by 2033, growing at a CAGR of 6.50% from 2024 to 2033.
Established Healthcare Sector: North
America to Sustain as a Leader North America holds the largest market
share in the tissue expanders market as the United States and Canada become the
leading countries for the market’s expansion. The U.S. research and development
sector is expected to experience new growth driven by increasing investments
and technological integration. The sector is experiencing unprecedented
excitement and transformative developments. From state-of-the-art diagnostic devices to
revolutionary therapeutic equipment, portable
medical devices sector is not only meeting the evolving needs of healthcare but
also shaping the future of medicine. Implant reconstruction using the two-stage
saline tissue expanders-to-implant technique is the most commonly used breast
reconstruction technique in the United States. ·
In August 2023, Sientra's silicone breast implant
is indicated for breast augmentation and breast reconstruction in women aged 22
years. In two-stage reconstruction, temporary breast tissue is used to create a
new breast pocket that will hold the breast for a long time. Digital Transformation and Evolving
Techniques: Market to Expand in Asian Countries Asia-Pacific is the fastest-growing tissue expanders
market during the forecast period as healthcare providers in the region
increasingly use technology, including AI and cloud technology, in their standards
of care. Alongside, the medical technology industry has been greatly impacted
by the rapid changes in economic society, economic crisis, and healthcare worker
shortages. Additionally, the popularity of direct-to-implant implantation is
increasing, and a 2-stage tissue expander (TE)-to-to-implant procedure remains,
by far, the most common technique for reconstruction. ·
In September 2024, a major
advancement in breast cancer treatment, ACTREC (Advanced Centre
for Treatment, Research and Education in Cancer) launched a new method for
reconstructing the entire breast after mastectomy. This method is less painful
and eliminates the risks associated with donor site complications found in
traditional techniques. The results are comparable to reconstructive surgery of
similar cost of reconstructive procedures. Tissue Expanders Market Segmentation ·
By Shape, the anatomical segment dominated in the tissue expanders market as it is
used exclusively in breast reconstruction to create a ptotic expanded envelope
mimicking the breast shape and proportions. Once the skin expansion envelope is
exhausted, implants are placed in its place. ·
By Application, the
breast reconstruction segment dominated and sustained to be the fastest-growing
tissue expanders market as tissue expanders are used after
a mastectomy to increase the number of tissue doctors when reconstructing or
implanting breasts. Breast implants play an important role in the reconstructive
armamentarium but should be used in carefully selected patients. ·
By end-user, the
hospital segment dominated the tissue expanders healthcare
provider inserts tissue expanders that help tighten and rejuvenate the skin.
This procedure is very common in breast reconstructive surgery. However,
surgeons can also use the expanders to increase tissue to repair skin damage
elsewhere in the body. As the expanders fill, new skin grows and existing skin
stretches. Tissue Expanders Market Top Companies ·
Mentor Worldwide LLC ·
PMT Corporation ·
AbbVie Inc. ·
Sientra, Inc. ·
Sebbin ·
Guangzhou Wanhe Plastic Material Co.,Ltd ·
KOKEN CO., LTD. ·
GC Aesthetics ·
POLYTECH Health & Aesthetics GmbH Browse More Press Releases: ·
DNA
Forensics Market Size to Surpass USD 5.52 billion by 2033
·
Cosmetovigilance
Market Size Expected to Reach USD 17.60 Bn by 2033
·
Bispecific
Antibodies Market Size Projected to Reach USD 484.88 Bn by 2034
·
Atopic
Dermatitis Clinical Trials Market Size to Hit USD 7.07 Bn by 2033
·
Skin Repair Market Size to Exceed USD 150.30 Bn by 2033 What is Going Around the Globe? ·
In January 2024, Establishment
Labs Holdings Inc., a global medical company dedicated to improving the health
and well-being of women primarily through breast augmentation and
reconstruction, announced the first U.S. export of its MotivaFlora SmoothSilk Tissue
Expanders was used for the first time in the United States at the University of
Texas MD Anderson Cancer Center in Houston by Mark Clemens, MD MBA FACS,
Professor of Plastic Surgery. The first surgery recently approved by the FDA is
a major advancement in plastic and reconstructive surgery. ·
In June 2024, Moon
Surgical, a French-American pioneer in surgical innovation, announced that the
U.S. Food and Drug Administration (FDA) has cleared the commercial version of
its unique Maestro Surgical System. ·
In January 2024,
Herons Therapeutics, Inc. a commercial-stage biotechnology company, announced
that the U.S. Food and Drug Administration has approved its supplemental New
Drug Application for ZYNRELEF extended-release solution to expand the
indication for soft tissue and orthopedic surgical procedures including foot
and ankle, and other procedures in which direct exposure to articular cartilage
is avoided. ·
In February 2024,
Anika Therapeutics, Inc., a global joint preservation company, announced that
it is focused on new products in the integrated and high-growth segments of
joint preservation and restoration from its Regenerative Solutions, Sports
Medicine, and Arthrosurface Joint Solutions businesses. ·
In July 2024, Stryker's
CEO approved robotics for possible soft-tissue surgical. Stryker
reported another strong quarter of sales and raised its full-year guidance as
it continued its aggressive merger and acquisition activity. Segments Covered in the Report: By Shape ·
Anatomical ·
Round ·
Rectangular ·
Crescent ·
Others
By Application ·
Breast
Reconstruction o Two-stage Breast
Reconstruction o Single-stage Breast
Reconstruction ·
Forehead
Skin and Scalp Reconstruction ·
Face
and Neck Reconstruction ·
Others
By End-use ·
Hospitals ·
Cosmetology
Clinics ·
Ambulatory
Surgical Centers
By Geography ·
North
America ·
Europe ·
Asia-Pacific ·
Latin
America ·
Middle
East and Africa
Thanks for reading you can also get
individual chapter-wise sections or region-wise report versions such as North
America, Europe, or Asia Pacific. Immediate Delivery Available | Buy This
Premium Research Report@ https://www.precedenceresearch.com/checkout/4017 You can place an
order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344 About Us Precedence Research is a worldwide market
research and consulting organization. We give an unmatched nature of offering
to our customers present all around the globe across industry verticals.
Precedence Research has expertise in giving deep-dive market insight along with
market intelligence to our customers spread crosswise over various
undertakings. We are obliged to serve our different client base present over
the enterprises of medicinal services, healthcare, innovation, next-gen
technologies, semi-conductors, chemicals, automotive, and aerospace &
defense, among different ventures present globally. Web: https://www.precedenceresearch.com Our Blogs: https://www.towardshealthcare.com https://www.towardspackaging.com https://www.towardsevsolutions.com For Latest Update Follow Us:
The increasing incidence of breast cancer globally
continues to drive demand for breast reconstruction procedures, a key
application of tissue expanders. Many women who undergo mastectomies opt for
reconstructive surgery to restore the appearance of the breast. As awareness
grows about reconstructive options, the demand for tissue expanders has surged,
with an emphasis on both aesthetic outcomes and patient quality of life.
Innovations in tissue expander technology are
transforming the market. Manufacturers are focusing on creating self-inflating
expanders, which eliminate the need for frequent saline injections, offering
greater convenience for patients and reducing the number of follow-up visits to
the doctor. Moreover, newer materials and improved designs are making tissue
expanders more comfortable, easier to use, and more efficient in facilitating
tissue growth.
As the demand for minimally invasive surgical
options increases, tissue expanders are being increasingly integrated into less
invasive procedures. Advances in surgical techniques allow for smaller
incisions and quicker recovery times, making breast reconstruction using tissue
expanders more attractive to patients.